ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ABOS Acumen Pharmaceuticals Inc

3.15
-0.01 (-0.32%)
20 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Acumen Pharmaceuticals Inc ABOS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.01 -0.32% 3.15 06:30:00
Open Price Low Price High Price Close Price Previous Close
3.24 3.10 3.30 3.15 3.16
more quote information »

Recent News

Date Time Source Heading
16/4/202422:00GLOBEAcumen Pharmaceuticals Presents First Comprehensive Clinical..
04/4/202423:00GLOBEAcumen Pharmaceuticals Collaborates with Lonza to Advance..
26/3/202422:00GLOBEAcumen Pharmaceuticals Reports Financial Results for the..
21/3/202423:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights, Including..
20/3/202407:00GLOBEAcumen Pharmaceuticals to Report Fourth Quarter and Year-End..
13/3/202407:00GLOBEAcumen Pharmaceuticals to Participate in the Stifel 2024 CNS..
09/3/202400:50GLOBEAcumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid..
22/2/202400:00GLOBEAcumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid..
15/2/202400:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202409:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202409:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/2/202423:16EDGAR2Form 8-K - Current report
01/2/202423:00GLOBEAcumen Pharmaceuticals Appoints Dr. James Doherty as..
20/1/202411:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202411:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202411:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202411:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202411:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:36EDGAR2Form 144 - Report of proposed sale of securities
20/1/202408:35EDGAR2Form 144 - Report of proposed sale of securities
19/1/202408:29EDGAR2Form 144 - Report of proposed sale of securities
19/1/202408:28EDGAR2Form 144 - Report of proposed sale of securities
19/1/202408:27EDGAR2Form 144 - Report of proposed sale of securities
13/1/202400:42EDGAR2Form 8-K - Current report
09/1/202400:33EDGAR2Form 8-K - Current report
05/1/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:15GLOBEAcumen Pharmaceuticals to Present at the 42nd Annual J.P...
04/12/202323:45EDGAR2Form 8-K - Current report
14/11/202309:10EDGAR2Form 8-K - Current report
14/11/202308:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202323:20EDGAR2Form 8-K - Current report
13/11/202323:00GLOBEAcumen Pharmaceuticals Reports Third Quarter 2023 Financial..
08/11/202308:01GLOBEAcumen Pharmaceuticals to Participate in the Stifel..
07/11/202308:01GLOBEAcumen Pharmaceuticals to Report Third Quarter Financial..
06/11/202323:30GLOBEAcumen Pharmaceuticals, Inc. and Halozyme Enter Global..
03/11/202307:00GLOBEAcumen Pharmaceuticals to Participate in the UBS Biopharma..
28/10/202300:25GLOBEAcumen Pharmaceuticals Presents Late-Breaker Phase 1 Updates..
04/10/202323:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights from..
20/9/202306:00GLOBEAcumen Pharmaceuticals to Participate in the Cantor Global..
07/9/202306:00GLOBEAcumen Pharmaceuticals to Participate in the H.C. Wainwright..
19/8/202308:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202301:46EDGAR2Form 144 - Report of proposed sale of securities
09/8/202306:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202321:33EDGAR2Form 8-K - Current report
08/8/202321:00GLOBEAcumen Pharmaceuticals Reports Second Quarter 2023 Financial..
02/8/202306:00GLOBEAcumen Pharmaceuticals to Report Second Quarter Financial..

Your Recent History

Delayed Upgrade Clock